510(k) K242095

Access Toxo IgM II by Beckman Coulter, Inc. — Product Code LGD

K242095 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access Toxo IgM II". The FDA issued a decision of Substantially Equivalent on October 11, 2024. The device falls under product code LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii), a Class II device regulated under 21 CFR 866.3780. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 11, 2024
Date Received
July 17, 2024
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Device Class
Class II
Regulation Number
866.3780
Review Panel
MI
Submission Type